Oramed Pharmaceuticals ORMP
NASDAQ ORMP
$4.13 +0.01 (+0.24%)
At close: Oct 23, 2026 · 4:00 PM EDT

Oramed Pharmaceuticals (ORMP) Gains from Investment Securities (2011 - 2026)

Updated

Oramed Pharmaceuticals' Gains from Investment Securities came in at -$86.1 million for FY2025, compared with $7.41 million in FY2024.

Analysis

Oramed Pharmaceuticals (ORMP) Gains from Investment Securities (2011 - 2026) Analysis & Trends

  • Per Business Quant, earlier years put Gains from Investment Securities at $7.41 million in FY2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,199.50 Bn 1,168.08 Bn 19.71 Bn
2 Johnson & Johnson 635.17 Bn 555.03 Bn 17.30 Bn
3 AbbVie 504.69 Bn 477.85 Bn 12.70 Bn
4 Merck 358.43 Bn 312.86 Bn 12.21 Bn
5 Novartis Ag 288.36 Bn 252.75 Bn 11.24 Bn
6 Astrazeneca 265.78 Bn 239.54 Bn 12.86 Bn
7 Amgen 237.46 Bn 192.86 Bn 7.24 Bn
8 Gilead Sciences 193.65 Bn 167.76 Bn 6.22 Bn
9 Pfizer 171.05 Bn 118.00 Bn 10.94 Bn
10 Oramed Pharmaceuticals 170.63 Mn -164.11 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 103.62 Mn
Mar 31, 2026 44.85 Mn
Dec 31, 2025 -158.69 Mn
Sep 30, 2025 61.16 Mn
Jun 30, 2025 14.78 Mn
Mar 31, 2025 -3.35 Mn
Dec 31, 2024 7.27 Mn
Sep 30, 2024 -16.58 Mn
May 31, 2014 35,609.00
Feb 28, 2014 25,937.00
Nov 30, 2013 18,454.00
Aug 31, 2013 -19,178.00
May 31, 2013 24,479.00
Nov 30, 2012 44,699.00
May 31, 2011 1.03 Mn
API Access

Oramed Pharmaceuticals Gains from Investment Securities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=gains-from-investment-securities&ticker=ORMP&period=max&api_key=YOUR_API_KEY